Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease
- PMID: 35325076
- PMCID: PMC9455788
- DOI: 10.1093/ecco-jcc/jjac041
Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease
Abstract
Background and aims: Alterations in body composition are common in inflammatory bowel disease [IBD] and have been associated with differences in patient outcomes. We sought to consolidate knowledge on the impact and importance of body composition in IBD.
Methods: We performed a systematic search of MEDLINE, EMBASE and conference proceedings by combining two key research themes: inflammatory bowel disease and body composition.
Results: Fifty-five studies were included in this review. Thirty-one focused on the impact of IBD on body composition with a total of 2279 patients with a mean age 38.4 years. Of these, 1071 [47%] were male. In total, 1470 [64.5%] patients had Crohn's disease and 809 [35.5%] had ulcerative colitis. Notably, fat mass and fat-free mass were reduced, and higher rates of sarcopaenia were observed in those with active IBD compared with those in clinical remission and healthy controls. Twenty-four additional studies focused on the impact of derangements in body composition on IBD outcomes. Alterations in body composition in IBD are associated with poorer prognoses including higher rates of surgical intervention, post-operative complications and reduced muscle strength. In addition, higher rates of early treatment failure and primary non-response are seen in patients with myopaenia.
Conclusions: Patients with IBD have alterations in body composition parameters in active disease and clinical remission. The impacts of body composition on disease outcome and therapy are broad and require further investigation. The augmentation of body composition parameters in the clinical setting has the potential to improve IBD outcomes in the future.
Keywords: Body composition; fat mass; inflammatory bowel disease; muscle mass.
© The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures
References
-
- Bryant RV, Ooi S, Schultz CG, et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:895–906. - PubMed
-
- Tjellesen L, Nielsen PK, Staun M.. Body composition by dual-energy X-ray absorptiometry in patients with Crohn’s disease. Scand J Gastroenterol 1998;33:956–60. - PubMed
-
- Thangarajah D, Hyde MJ, Konteti VK, Santhakumaran S, Frost G, Fell JM.. Systematic review: body composition in children with inflammatory bowel disease. Aliment Pharmacol Ther 2015;42:142–57. - PubMed
-
- Jahnsen J, Falch JA, Mowinckel P, Aadland E.. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 2003;98:1556–62. - PubMed
-
- Sousa Guerreiro C, Cravo M, Costa AR, et al. A comprehensive approach to evaluate nutritional status in Crohn’s patients in the era of biologic therapy: a case-control study. Am J Gastroenterol 2007;102:2551–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
